258 related articles for article (PubMed ID: 35164900)
1. Patient-specific Boolean models of signalling networks guide personalised treatments.
Montagud A; Béal J; Tobalina L; Traynard P; Subramanian V; Szalai B; Alföldi R; Puskás L; Valencia A; Barillot E; Saez-Rodriguez J; Calzone L
Elife; 2022 Feb; 11():. PubMed ID: 35164900
[TBL] [Abstract][Full Text] [Related]
2. Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines.
von der Heyde S; Bender C; Henjes F; Sonntag J; Korf U; Beißbarth T
BMC Syst Biol; 2014 Jun; 8():75. PubMed ID: 24970389
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer.
Jansson KH; Tucker JB; Stahl LE; Simmons JK; Fuller C; Beshiri ML; Agarwal S; Fang L; Hynes PG; Alilin AN; Lake R; Abbey YC; Cawley J; Tice CM; Yin J; McKnight C; Klummp-Thomas C; Zhang X; Guha R; Hoover S; Simpson RM; Nguyen HM; Corey E; Thomas CJ; Proia DA; Kelly K
Sci Rep; 2018 Nov; 8(1):17239. PubMed ID: 30467317
[TBL] [Abstract][Full Text] [Related]
4. Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance.
Harrison PT; Huang PH
Essays Biochem; 2018 Oct; 62(4):583-593. PubMed ID: 30072489
[TBL] [Abstract][Full Text] [Related]
5. Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.
Gandhi N; Wild AT; Chettiar ST; Aziz K; Kato Y; Gajula RP; Williams RD; Cades JA; Annadanam A; Song D; Zhang Y; Hales RK; Herman JM; Armour E; DeWeese TL; Schaeffer EM; Tran PT
Cancer Biol Ther; 2013 Apr; 14(4):347-56. PubMed ID: 23358469
[TBL] [Abstract][Full Text] [Related]
6. Respiratory healthcare by design: Computational approaches bringing respiratory precision and personalised medicine closer to bedside.
Kaul H
Morphologie; 2019 Dec; 103(343):194-202. PubMed ID: 31711740
[TBL] [Abstract][Full Text] [Related]
7. Personalising Prostate Radiotherapy in the Era of Precision Medicine: A Review.
Spence W
J Med Imaging Radiat Sci; 2018 Dec; 49(4):376-382. PubMed ID: 30514554
[TBL] [Abstract][Full Text] [Related]
8. Applications of personalised signalling network models in precision oncology.
Hastings JF; O'Donnell YEI; Fey D; Croucher DR
Pharmacol Ther; 2020 Aug; 212():107555. PubMed ID: 32320730
[TBL] [Abstract][Full Text] [Related]
9. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.
Armstrong HK; Koay YC; Irani S; Das R; Nassar ZD; ; Selth LA; Centenera MM; McAlpine SR; Butler LM
Prostate; 2016 Dec; 76(16):1546-1559. PubMed ID: 27526951
[TBL] [Abstract][Full Text] [Related]
10. Clusterin inhibition using OGX-011 synergistically enhances Hsp90 inhibitor activity by suppressing the heat shock response in castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Kuruma H; Beraldi E; Fazli L; Zoubeidi A; Gleave ME
Cancer Res; 2011 Sep; 71(17):5838-49. PubMed ID: 21737488
[TBL] [Abstract][Full Text] [Related]
11. The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.
Lundon DJ; Boland A; Prencipe M; Hurley G; O'Neill A; Kay E; Aherne ST; Doolan P; Madden SF; Clynes M; Morrissey C; Fitzpatrick JM; Watson RW
BMC Cancer; 2017 Mar; 17(1):163. PubMed ID: 28249598
[TBL] [Abstract][Full Text] [Related]
12. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
13. Networks and games for precision medicine.
Biane C; Delaplace F; Klaudel H
Biosystems; 2016 Dec; 150():52-60. PubMed ID: 27543134
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer.
Calvo A; Perez-Stable C; Segura V; Catena R; Guruceaga E; Nguewa P; Blanco D; Parada L; Reiner T; Green JE
Prostate; 2010 May; 70(6):630-45. PubMed ID: 20058236
[TBL] [Abstract][Full Text] [Related]
15. Signalling pathways in prostate carcinogenesis: potentials for molecular-targeted therapy.
Ramsay AK; Leung HY
Clin Sci (Lond); 2009 Aug; 117(6):209-28. PubMed ID: 19663810
[TBL] [Abstract][Full Text] [Related]
16. Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance.
Tomer A; Nieboer D; Roobol MJ; Bjartell A; Steyerberg EW; Rizopoulos D;
BJU Int; 2021 Jan; 127(1):96-107. PubMed ID: 32531869
[TBL] [Abstract][Full Text] [Related]
17. Advances in the role of heat shock protein 90 in prostate cancer.
Fu Z; Jia B
Andrologia; 2022 May; 54(4):e14376. PubMed ID: 35075667
[TBL] [Abstract][Full Text] [Related]
18. Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells.
Eguchi T; Sogawa C; Ono K; Matsumoto M; Tran MT; Okusha Y; Lang BJ; Okamoto K; Calderwood SK
Cells; 2020 Mar; 9(3):. PubMed ID: 32204513
[TBL] [Abstract][Full Text] [Related]
19. The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.
Palanisamy N; Yang J; Shepherd PDA; Li-Ning-Tapia EM; Labanca E; Manyam GC; Ravoori MK; Kundra V; Araujo JC; Efstathiou E; Pisters LL; Wan X; Wang X; Vazquez ES; Aparicio AM; Carskadon SL; Tomlins SA; Kunju LP; Chinnaiyan AM; Broom BM; Logothetis CJ; Troncoso P; Navone NM
Clin Cancer Res; 2020 Sep; 26(18):4933-4946. PubMed ID: 32576626
[TBL] [Abstract][Full Text] [Related]
20. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
